Jacobson Pharma Corporation Limited (2633.HK)
HKD 1.21
(-0.82%)
HKD 1.21
(-0.82%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.46 Billion | 1.78 Billion | 1.59 Billion | 1.44 Billion | 1.57 Billion | 1.47 Billion |
| Cost of Revenue | 847.32 Million | 1.03 Billion | 975.02 Million | 911.76 Million | 901.7 Million | 803.47 Million |
| Gross Profit | 620.47 Million | 747.17 Million | 620.52 Million | 534.14 Million | 669.75 Million | 674.65 Million |
| Operating Expenses | 287.34 Million | 428.07 Million | 397.63 Million | 348.64 Million | 374.32 Million | 304.09 Million |
| Selling, General and Administrative Expenses | 332.37 Million | 426.9 Million | 390.98 Million | 346.86 Million | 370.58 Million | 341.13 Million |
| Research and Development Expenses | - | 1.16 Million | 6.64 Million | 1.78 Million | 3.73 Million | 2.6 Million |
| Other Expenses | -45.02 Million | 30.97 Million | 25.57 Million | 10.82 Million | 15.04 Million | 5.61 Million |
| Cost and Expenses | 1.13 Billion | 1.46 Billion | 1.37 Billion | 1.26 Billion | 1.27 Billion | 1.1 Billion |
| Operating Income | 333.12 Million | 319.1 Million | 222.88 Million | 185.5 Million | 295.43 Million | 339.06 Million |
| Interest Expense | 78.7 Million | 67.44 Million | 25.68 Million | 30.14 Million | 55.35 Million | 66.19 Million |
| Income Tax Expense | 44.41 Million | 56.54 Million | 43.72 Million | 34.26 Million | 46.02 Million | 55.52 Million |
| Earnings before Tax | 254.58 Million | 343.31 Million | 235.2 Million | 226.09 Million | 262.85 Million | 309.1 Million |
| Net Income | 266.96 Million | 251.04 Million | 177.66 Million | 173.71 Million | 215.63 Million | 250.56 Million |
| Earnings Per Share Basic | 0.12 | 0.13 | 0.09 | 0.09 | 0.11 | 0.13 |
| Earnings Per Share Diluted | 0.12 | 0.13 | 0.09 | 0.09 | 0.11 | 0.13 |
| Weighted Average Shares Outstanding | 1.92 Billion | 1.91 Billion | 1.91 Billion | 1.91 Billion | 1.98 Billion | 1.93 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.92 Billion | 1.91 Billion | 1.91 Billion | 1.91 Billion | 1.98 Billion | 1.93 Billion |
| Gross Margin | 0.42 | 0.42 | 0.39 | 0.37 | 0.43 | 0.46 |
| EBIT Margin | 0.29 | 0.28 | 0.26 | 0.26 | 0.29 | 0.30 |
| Profit Margin | 0.18 | 0.14 | 0.11 | 0.12 | 0.14 | 0.17 |
| EBITDA | 429.92 Million | 462.03 Million | 415.48 Million | 377.2 Million | 484.48 Million | 448.34 Million |
| Earnings Before Tax Margin | 0.23 | 0.18 | 0.14 | 0.13 | 0.19 | 0.23 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 752.88 Million | 1.46 Billion | 714.91 Million | 968.22 Million | 1.78 Billion | 817.35 Million |
| Cost of Revenue | 433.48 Million | 847.32 Million | 413.83 Million | 561.48 Million | 1.03 Billion | 476.92 Million |
| Gross Profit | 319.39 Million | 620.47 Million | 301.07 Million | 406.74 Million | 747.17 Million | 340.42 Million |
| Operating Expenses | 152.24 Million | 332.37 Million | 162.59 Million | 239.72 Million | 428.07 Million | 188.34 Million |
| Selling, General and Administrative Expenses | 169.78 Million | - | 162.59 Million | 239.72 Million | - | 188.34 Million |
| Research and Development Expenses | 6.45 Million | - | - | 2.12 Million | - | - |
| Other Expenses | -23.98 Million | 23.21 Million | - | - | 30.97 Million | - |
| Cost and Expenses | 585.72 Million | 1.17 Billion | 576.43 Million | 801.2 Million | 1.46 Billion | 665.26 Million |
| Operating Income | 167.15 Million | 288.09 Million | 138.48 Million | 167.01 Million | 319.1 Million | 152.08 Million |
| Interest Expense | 31.26 Million | 78.7 Million | 47.44 Million | 45.19 Million | 67.44 Million | 22.25 Million |
| Income Tax Expense | 22.83 Million | 44.41 Million | 21.57 Million | 27.14 Million | 56.54 Million | 29.4 Million |
| Earnings before Tax | 135.72 Million | 254.41 Million | 118.52 Million | 164.52 Million | 343.31 Million | 178.78 Million |
| Net Income | 112.92 Million | 266.96 Million | 125.82 Million | 114.85 Million | 251.04 Million | 136.19 Million |
| Earnings Per Share Basic | 0.06 | - | 0.07 | 0.06 | - | 0.07 |
| Earnings Per Share Diluted | 0.06 | - | 0.07 | 0.06 | - | 0.07 |
| Weighted Average Shares Outstanding | 1.93 Billion | 1.92 Billion | 1.91 Billion | 1.9 Billion | 1.91 Billion | 1.91 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.92 Billion | 1.92 Billion | 1.91 Billion | 1.9 Billion | 1.91 Billion | 1.91 Billion |
| Gross Margin | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| EBIT Margin | 0.33 | - | 0.29 | 0.27 | - | 0.30 |
| Profit Margin | 0.15 | 0.18 | 0.18 | 0.12 | 0.14 | 0.17 |
| EBITDA | 248.12 Million | - | 209.88 Million | 258.76 Million | - | 244.79 Million |
| Earnings Before Tax Margin | 0.22 | 0.20 | 0.19 | 0.17 | 0.18 | 0.19 |
ADEA
E5H
8018
6690
SCPPF
3204